PMID- 37702657 OWN - NLM STAT- MEDLINE DCOM- 20231204 LR - 20240209 IS - 1538-7445 (Electronic) IS - 0008-5472 (Print) IS - 0008-5472 (Linking) VI - 83 IP - 23 DP - 2023 Dec 1 TI - CK1delta and CK1epsilon Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma. PG - 3901-3919 LID - 10.1158/0008-5472.CAN-22-2350 [doi] AB - Multiple myeloma remains an incurable malignancy due to acquisition of intrinsic programs that drive therapy resistance. Here we report that casein kinase-1delta (CK1delta) and CK1epsilon are therapeutic targets in multiple myeloma that are necessary to sustain mitochondrial metabolism. Specifically, the dual CK1delta/CK1epsilon inhibitor SR-3029 had potent in vivo and ex vivo anti-multiple myeloma activity, including against primary multiple myeloma patient specimens. RNA sequencing (RNA-seq) and metabolic analyses revealed inhibiting CK1delta/CK1epsilon disables multiple myeloma metabolism by suppressing genes involved in oxidative phosphorylation (OxPhos), reducing citric acid cycle intermediates, and suppressing complexes I and IV of the electron transport chain. Finally, sensitivity of multiple myeloma patient specimens to SR-3029 correlated with elevated expression of mitochondrial genes, and RNA-seq from 687 multiple myeloma patient samples revealed that increased CSNK1D, CSNK1E, and OxPhos genes correlate with disease progression and inferior outcomes. Thus, increases in mitochondrial metabolism are a hallmark of multiple myeloma progression that can be disabled by targeting CK1delta/CK1epsilon. SIGNIFICANCE: CK1delta and CK1epsilon are attractive therapeutic targets in multiple myeloma whose expression increases with disease progression and connote poor outcomes, and that are necessary to sustain expression of genes directing OxPhos. CI - (c)2023 The Authors; Published by the American Association for Cancer Research. FAU - Burger, Karen L AU - Burger KL AUID- ORCID: 0000-0002-3805-9580 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Fernandez, Mario R AU - Fernandez MR AUID- ORCID: 0000-0002-2017-9576 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Meads, Mark B AU - Meads MB AUID- ORCID: 0009-0008-0259-1875 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Sudalagunta, Praneeth AU - Sudalagunta P AUID- ORCID: 0000-0003-1283-9332 AD - Department of Metabolism & Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Oliveira, Paula S AU - Oliveira PS AUID- ORCID: 0009-0007-2128-7302 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Renatino Canevarolo, Rafael AU - Renatino Canevarolo R AUID- ORCID: 0000-0002-8722-8512 AD - Department of Metabolism & Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Alugubelli, Raghunandan Reddy AU - Alugubelli RR AUID- ORCID: 0000-0002-4314-1204 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Tungsevik, Alexandre AU - Tungsevik A AUID- ORCID: 0009-0003-5208-5886 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - De Avila, Gabe AU - De Avila G AUID- ORCID: 0000-0003-3826-862X AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Silva, Maria AU - Silva M AUID- ORCID: 0009-0008-6787-6695 AD - Department of Metabolism & Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Graeter, Allison I AU - Graeter AI AUID- ORCID: 0000-0001-6782-0298 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Dai, Hongyue A AU - Dai HA AUID- ORCID: 0000-0002-6609-9141 AD - Informatics Division, M2Gen(R), Tampa, Florida. FAU - Vincelette, Nicole D AU - Vincelette ND AUID- ORCID: 0000-0001-7627-6781 AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Prabhu, Antony AU - Prabhu A AUID- ORCID: 0000-0003-2401-0118 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Magaletti, Dario AU - Magaletti D AUID- ORCID: 0009-0005-2371-9290 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Yang, Chunying AU - Yang C AUID- ORCID: 0000-0001-8188-0860 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Li, Weimin AU - Li W AUID- ORCID: 0000-0001-7815-0859 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Kulkarni, Amit AU - Kulkarni A AUID- ORCID: 0009-0000-4624-4789 AD - Informatics Division, M2Gen(R), Tampa, Florida. FAU - Hampton, Oliver AU - Hampton O AUID- ORCID: 0000-0001-9164-1070 AD - Informatics Division, M2Gen(R), Tampa, Florida. FAU - Koomen, John M AU - Koomen JM AUID- ORCID: 0000-0002-3818-1762 AD - Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Roush, William R AU - Roush WR AUID- ORCID: 0000-0001-9785-5897 AD - Department of Chemistry, Scripps Research, Jupiter, Florida. FAU - Monastyrskyi, Andrii AU - Monastyrskyi A AUID- ORCID: 0000-0002-1145-1822 AD - Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Berglund, Anders E AU - Berglund AE AUID- ORCID: 0000-0002-0393-3530 AD - Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Silva, Ariosto S AU - Silva AS AUID- ORCID: 0000-0003-3237-9986 AD - Department of Metabolism & Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Cleveland, John L AU - Cleveland JL AUID- ORCID: 0000-0002-7561-9065 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. FAU - Shain, Kenneth H AU - Shain KH AUID- ORCID: 0000-0003-4178-8888 AD - Department of Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. AD - Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. LA - eng GR - F32 CA203217/CA/NCI NIH HHS/United States GR - P30 CA076292/CA/NCI NIH HHS/United States GR - U54 CA193489/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - EC 2.7.11.1 (Casein Kinase Idelta) SB - IM MH - Humans MH - *Casein Kinase Idelta/genetics/metabolism MH - *Multiple Myeloma/genetics MH - Cell Survival MH - Phosphorylation MH - Disease Progression PMC - PMC10690099 EDAT- 2023/09/13 12:42 MHDA- 2023/12/04 12:42 PMCR- 2023/12/01 CRDT- 2023/09/13 10:33 PHST- 2022/07/24 00:00 [received] PHST- 2023/06/09 00:00 [revised] PHST- 2023/09/08 00:00 [accepted] PHST- 2023/12/04 12:42 [medline] PHST- 2023/09/13 12:42 [pubmed] PHST- 2023/09/13 10:33 [entrez] PHST- 2023/12/01 00:00 [pmc-release] AID - 729039 [pii] AID - CAN-22-2350 [pii] AID - 10.1158/0008-5472.CAN-22-2350 [doi] PST - ppublish SO - Cancer Res. 2023 Dec 1;83(23):3901-3919. doi: 10.1158/0008-5472.CAN-22-2350.